Completed PHASE1 INTERVENTIONAL 1-arm NCT01062347

A Novel Bio-marker of Zinc Status

Exploring the Possibility of Using Intestinal mRNA Levels of Zinc Transporter Genes, and Changes in Their Expression Levels in Response to Zinc Supplementation as a Bio-marker for Zinc Status

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh

Conditions Zinc Deficiency

Interventions Zinc

Updated 6 times since 2017 Last updated: Jun 6, 2017 Started: Jul 1, 2007 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01062347, this PHASE1 trial focuses on Zinc Deficiency and remains completed. Sponsored by International Centre for Diarrhoeal Disease Research, Bangladesh, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jun 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Completed PHASE1

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

International Centre for Diarrhoeal Disease Research, Bangladesh
University of California, Davis

Data source: International Centre for Diarrhoeal Disease Research, Bangladesh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dhaka, Bangladesh